|Articles|April 1, 2003
- Pharmaceutical Executive-04-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
In the Eye of the Stormover 22 years ago
Pharma WANTS YOUover 22 years ago
What They're Not Sayingover 22 years ago
Generic Treatment Claims: Do They Hold Water?over 22 years ago
Generics Battle Heats Upover 22 years ago
HBA's 2003 Woman of the YearNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
FDA Continues to Expand National Priority Voucher Program
4
In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore
5
